N-Nitroso Escitalopram EP Impurity D/N-Nitroso Desmethylcitalopram
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Escitalopram is used to treat depression and generalized anxiety disorder (GAD). It is an antidepressant that belongs to a group of medicines known as selective serotonin reuptake inhibitors (SSRIs). These medicines work by increasing the activity of the chemical serotonin in the brain.N-Nitroso Escitalopram EP Impurity D is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Escitalopram EP Impurity D CAS NO:NA chemically represented as N-(3-(5-Cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl)propyl)-N-methylnitrous amide and it is also known as N-Nitroso Desmethylcitalopram .Synchemia is the leading manufacturing and exporter of N-Nitroso Escitalopram EP Impurity D.We supply N-Nitroso Escitalopram EP Impurity D with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142691 |
| CAS No | NA |
| Mol.F. | C11H11N3O4 |
| Mol.Wt. | g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142692 |
| CAS No | NA |
| Mol.F. | C26H23N7O4 |
| Mol.Wt. | 497.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142694 |
| CAS No | NA |
| Mol.F. | C33H33N7O7 |
| Mol.Wt. | 639.67 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142695 |
| CAS No | NA |
| Mol.F. | C33H33N7O7 |
| Mol.Wt. | 639.67 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142696 |
| CAS No | NA |
| Mol.F. | C24H19N7O4 |
| Mol.Wt. | 469.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142697 |
| CAS No | NA |
| Mol.F. | C25H21N7O4 |
| Mol.Wt. | 483.49 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142698 |
| CAS No | NA |
| Mol.F. | C23H18N4O5 |
| Mol.Wt. | 430.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142699 |
| CAS No | NA |
| Mol.F. | C23H17N7O4 |
| Mol.Wt. | 455.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142700 |
| CAS No | NA |
| Mol.F. | C10H9N3O4 |
| Mol.Wt. | 235.20 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142701 |
| CAS No | NA |
| Mol.F. | C32H31N7O7 |
| Mol.Wt. | 625.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142702 |
| CAS No | NA |
| Mol.F. | C22H15N7O4 |
| Mol.Wt. | 441.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142703 |
| CAS No | NA |
| Mol.F. | C8H6ClN3O3S |
| Mol.Wt. | 259.7 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142704 |
| CAS No | NA |
| Mol.F. | C7H4ClN3O4S |
| Mol.Wt. | 261.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142705 |
| CAS No | NA |
| Mol.F. | C8H9N3O4S |
| Mol.Wt. | 243.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142706 |
| CAS No | NA |
| Mol.F. | C8H7ClN2O5S |
| Mol.Wt. | 278.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142707 |
| CAS No | NA |
| Mol.F. | C15H21N3O2 |
| Mol.Wt. | 275.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |